zoledronic acid has been researched along with Lymphoma, Primary Effusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, H; Hattori, S; Kariya, R; Katano, H; Matsuda, K; Okada, S; Srikoon, P; Taura, M | 1 |
1 other study(ies) available for zoledronic acid and Lymphoma, Primary Effusion
| Article | Year |
|---|---|
Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma.
Topics: Animals; Cell Proliferation; Diphosphonates; Flow Cytometry; Humans; Imidazoles; Immunohistochemistry; Lymphoma, Primary Effusion; Mice; Mice, Inbred NOD; T-Lymphocytes; Xenograft Model Antitumor Assays; Zoledronic Acid | 2013 |